Carglumic Acid is a pharmaceutical compound used in the treatment of genetic disorders. However, the manufacturing process of Carglumic Acid can lead to the formation of impurities. These impurities can potentially affect the efficacy and safety of the drug. Therefore, it is important to monitor and control the levels of Carglumic Acid impurities to ensure the quality of the final product. Various analytical techniques such as HPLC and GC are used for the detection and quantification of these impurities.
